Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier

被引:58
作者
Iyen-Omofoman, Barbara [1 ]
Tata, Laila J. [1 ]
Baldwin, David R. [2 ]
Smith, Chris J. P. [1 ]
Hubbard, Richard B. [1 ,2 ,3 ]
机构
[1] Univ Nottingham, Dept Epidemiol & Publ Hlth, Nottingham NG5 1PB, England
[2] Nottingham Univ Hosp NHS Trust, Nottingham, England
[3] Univ Nottingham, Resp Biomed Res Unit, Nottingham NG5 1PB, England
基金
英国经济与社会研究理事会;
关键词
RISK PREDICTION MODEL; PRIMARY-CARE; SUSPECTED LUNG; DIAGNOSIS; SURVIVAL; ENGLAND; SYSTEM; CT;
D O I
10.1136/thoraxjnl-2012-202348
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction In the UK, most people with lung cancer are diagnosed at a late stage when curative treatment is not possible. To aid earlier detection, the socio-demographic and early clinical features predictive of lung cancer need to be identified. Methods We studied 12 074 cases of lung cancer and 120 731 controls in a large general practice database. Logistic regression analyses were used to identify the socio-demographic and clinical features associated with cancer up to 2 years before diagnosis. A risk prediction model was developed using variables that were independently associated with lung cancer up to 4 months before diagnosis. The model performance was assessed in an independent dataset of 1 826 293 patients from the same database. Discrimination was assessed by means of a receiver operating characteristic (ROC) curve. Results Clinical and socio-demographic features that were independently associated with lung cancer were patients' age, sex, socioeconomic status and smoking history. From 4 to 12 months before diagnosis, the frequency of consultations and symptom records of cough, haemoptysis, dyspnoea, weight loss, lower respiratory tract infections, non-specific chest infections, chest pain, hoarseness, upper respiratory tract infections and chronic obstructive pulmonary disease were also independently predictive of lung cancer. On validation, the model performed well with an area under the ROC curve of 0.88. Conclusions This new model performed substantially better than the current National Institute for Health and Clinical Excellence referral guidelines and all comparable models. It has the potential to predict lung cancer cases sufficiently early to make detection at a curable stage more likely by allowing general practitioners to better risk stratify their patients. A clinical trial is needed to quantify the absolute benefits to patients and the cost effectiveness of this model in practice.
引用
收藏
页码:451 / 459
页数:9
相关论文
共 30 条
  • [11] The Thoracic Surgery Scoring System (Thoracoscore): Risk model for in-hospital death in 15,183 patients requiring thoracic surgery
    Falcoz, Pierre Emmanuel
    Conti, Massimo
    Brouchet, Laurent
    Chocron, Sidney
    Puyraveau, Marc
    Mercier, Mariette
    Etievent, Joseph Philippe
    Dahan, Marcel
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (02) : 325 - 332
  • [12] Estimates of cancer incidence and mortality in Europe in 2008
    Ferlay, J.
    Parkin, D. M.
    Steliarova-Foucher, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) : 765 - 781
  • [13] Cancer risk prediction models: A workshop on development, evaluation, and application
    Freedman, AN
    Seminara, D
    Gail, MH
    Hartge, P
    Colditz, GA
    Ballard-Barbash, R
    Pfeiffer, RM
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (10): : 715 - 723
  • [14] What are the clinical features of lung cancer before the diagnosis is made? - A population based case-control study
    Hamilton, W
    Peters, TJ
    Round, A
    Sharp, D
    [J]. THORAX, 2005, 60 (12) : 1059 - 1065
  • [15] Diagnosis of lung cancer in primary care: a structured review
    Hamilton, W
    Sharp, D
    [J]. FAMILY PRACTICE, 2004, 21 (06) : 605 - 611
  • [16] Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm
    Hippisley-Cox, Julia
    Coupand, Carol
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2011, 61 (592) : e715 - e723
  • [17] National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up
    Holmberg, Lars
    Sandin, Fredrik
    Bray, Freddie
    Richards, Mike
    Spicer, James
    Lambe, Mats
    Klint, Asa
    Peake, Mick
    Strand, Trond-Eirik
    Linklater, Karen
    Robinson, David
    Moller, Henrik
    [J]. THORAX, 2010, 65 (05) : 436 - 441
  • [18] Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival
    Imperatori, A
    Harrison, RN
    Leitch, DN
    Rovera, F
    Lepore, G
    Dionigi, G
    Sutton, P
    Dominioni, L
    [J]. THORAX, 2006, 61 (03) : 232 - 239
  • [19] Screening for lung cancer: are we there yet?
    Infante, Maurizio V.
    Pedersen, Jesper H.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (04) : 301 - 306
  • [20] The distribution of lung cancer across sectors of society in the United Kingdom: a study using national primary care data
    Iyen-Omofoman, Barbara
    Hubbard, Richard B.
    Smith, Chris J. P.
    Sparks, Emily
    Bradley, Emma
    Bourke, Alison
    Tata, Laila J.
    [J]. BMC PUBLIC HEALTH, 2011, 11